Piekos Brian (CIK 1815308) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-11). Recent activity: Sell KALV (21,661 shares), Buy KALV (6,250 shares), Sell KALV (1,862 shares), Buy KALV (5,000 shares), Sell KALV (1,767 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Sell | 21,661 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Buy | 6,250 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Sell | 1,862 | $37,643 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Buy | 5,000 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Sell | 1,767 | $27,512 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Buy | 15,000 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Financial Officer | Sell | 4,471 | $60,135 |
Source: SEC Form 4 filings · as of 2026-06-11